MX341428B - Tableta de liberacion controlada de extracto de ginkgo biloba y procedimiento para su obtencion. - Google Patents

Tableta de liberacion controlada de extracto de ginkgo biloba y procedimiento para su obtencion.

Info

Publication number
MX341428B
MX341428B MX2011004417A MX2011004417A MX341428B MX 341428 B MX341428 B MX 341428B MX 2011004417 A MX2011004417 A MX 2011004417A MX 2011004417 A MX2011004417 A MX 2011004417A MX 341428 B MX341428 B MX 341428B
Authority
MX
Mexico
Prior art keywords
ginkgo biloba
procedure
obtaining
controlled release
biloba extract
Prior art date
Application number
MX2011004417A
Other languages
English (en)
Other versions
MX2011004417A (es
Inventor
Herrmann Joachim
Thöle Marc
Sven Jechlitschka Robert
Rothe Andreas
Original Assignee
Dr Willmar Schwabe Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Willmar Schwabe Gmbh & Co Kg filed Critical Dr Willmar Schwabe Gmbh & Co Kg
Priority to MX2011004417A priority Critical patent/MX341428B/es
Priority to ARP120101433A priority patent/AR086062A1/es
Priority to PCT/EP2012/057506 priority patent/WO2012146592A1/en
Priority to BR112013026236-2A priority patent/BR112013026236B1/pt
Priority to KR1020137026533A priority patent/KR101912642B1/ko
Priority to CN2012800144435A priority patent/CN103429230A/zh
Priority to EP12718174.1A priority patent/EP2701688B1/en
Publication of MX2011004417A publication Critical patent/MX2011004417A/es
Priority to CO13202735A priority patent/CO6791614A2/es
Publication of MX341428B publication Critical patent/MX341428B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una tableta de liberación controlada caracterizada porque consiste de: una mezcla de 52% -60% de extracto seco proveniente de las hojas de Ginkgo biloba en una matriz polimérica de 37%-45% de etilcelulosa, que además comprende 0.4%-1.0% de dióxido de silicio coloidal y 1.5%-2.5% estearato magnésico o ácido esteárico como excipientes. Proporciona una tableta novedosa de extracto de Ginkgo biloba en una matriz polimérica de etilcelulosa, producida mediante la comprensión del extracto seco de Ginkgo biloba junto con etilcelulosa, dióxido de silicio y estearato de magnesio o ácido esteárico; el perfil para liberación se puede optimizar y controlar a través de la variación de las proporciones de los diferentes ingredientes. También se incluye un procedimiento para obtener esta tableta.
MX2011004417A 2011-04-27 2011-04-27 Tableta de liberacion controlada de extracto de ginkgo biloba y procedimiento para su obtencion. MX341428B (es)

Priority Applications (8)

Application Number Priority Date Filing Date Title
MX2011004417A MX341428B (es) 2011-04-27 2011-04-27 Tableta de liberacion controlada de extracto de ginkgo biloba y procedimiento para su obtencion.
ARP120101433A AR086062A1 (es) 2011-04-27 2012-04-25 Tableta de liberacion controlada de extracto de ginkgo biloba y procedimiento para su obtencion
PCT/EP2012/057506 WO2012146592A1 (en) 2011-04-27 2012-04-25 Controlled release tablet of ginkgo biloba extract and procedure for obtaining it
BR112013026236-2A BR112013026236B1 (pt) 2011-04-27 2012-04-25 Comprimido de liberação controlada de extrato de ginkgo biloba e processo para a obtenção do mesmo
KR1020137026533A KR101912642B1 (ko) 2011-04-27 2012-04-25 은행나무 추출물의 방출 조절형 정제 및 이의 제조 방법
CN2012800144435A CN103429230A (zh) 2011-04-27 2012-04-25 银杏提取物的控制释放片剂和其获得程序
EP12718174.1A EP2701688B1 (en) 2011-04-27 2012-04-25 Controlled release tablet of ginkgo biloba extract and procedure for obtaining it
CO13202735A CO6791614A2 (es) 2011-04-27 2013-08-27 Cmprimido de liberación controlada de extracto de ginkgo biloba y procedimiento para obtenerlo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2011004417A MX341428B (es) 2011-04-27 2011-04-27 Tableta de liberacion controlada de extracto de ginkgo biloba y procedimiento para su obtencion.

Publications (2)

Publication Number Publication Date
MX2011004417A MX2011004417A (es) 2012-10-29
MX341428B true MX341428B (es) 2016-08-18

Family

ID=46025682

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011004417A MX341428B (es) 2011-04-27 2011-04-27 Tableta de liberacion controlada de extracto de ginkgo biloba y procedimiento para su obtencion.

Country Status (8)

Country Link
EP (1) EP2701688B1 (es)
KR (1) KR101912642B1 (es)
CN (1) CN103429230A (es)
AR (1) AR086062A1 (es)
BR (1) BR112013026236B1 (es)
CO (1) CO6791614A2 (es)
MX (1) MX341428B (es)
WO (1) WO2012146592A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102014202318B4 (de) 2014-02-10 2016-10-06 Dr. Willmar Schwabe Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von Ginkgoextrakten
CN103919768B (zh) * 2014-03-30 2016-03-16 吴静 一种含有异银杏双黄酮和白果内酯的药物组合物及其制剂
CN104042644A (zh) * 2014-06-25 2014-09-17 江苏大学 一种银杏酮酯自微乳制剂及其制备方法
CN104042643B (zh) * 2014-06-25 2017-09-22 江苏大学 一种银杏酮酯固体自微乳缓释微丸及其制备方法
CN104224859A (zh) * 2014-10-13 2014-12-24 北京人福军威医药技术开发有限公司 银杏叶提取物缓释微丸制剂
WO2017146286A1 (ko) * 2016-02-26 2017-08-31 에스케이케미칼주식회사 친수성서방폴리머의 매트릭스를 이용한 은행잎 추출물의 약학조성물 및 이를 이용한 경구용 서방성 제제
KR101992404B1 (ko) 2016-03-07 2019-06-24 에스케이케미칼 주식회사 친수성서방폴리머의 매트릭스를 이용한 은행잎 추출물의 약학조성물 및 이를 이용한 경구용 서방성 제제
KR101992394B1 (ko) 2016-03-07 2019-06-24 에스케이케미칼 주식회사 친수성서방폴리머의 매트릭스를 이용한 은행잎 추출물의 약학조성물 및 이를 이용한 경구용 서방성 제제
RS64615B1 (sr) 2019-01-15 2023-10-31 Dr Willmar Schwabe Gmbh & Co Kg Proces za proizvodnju tableta jednostavnih za uzimanje sa suvim ekstraktom iz listova ginko bilobe
WO2021260636A1 (en) * 2020-06-25 2021-12-30 Shyam Sunder Singh A pharmaceutical composition comprising l-carnosine and ginkgo biloba extract
KR20220041673A (ko) * 2020-09-25 2022-04-01 씨제이제일제당 (주) 은행잎을 포함하는 항콕시듐용 조성물 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3940091A1 (de) 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
DE102005061948A1 (de) 2005-05-03 2006-11-16 Bioplanta Arzneimittel Gmbh Verbessertes Verfahren zur Herstellung von 4'-O-Methylpyridoxin- und/oder Biflavon-armen Ginkgoextrakten
CN100341522C (zh) * 2005-05-16 2007-10-10 济南华诺医药科技有限公司 银杏叶缓释片及其制备方法
US20080171085A1 (en) * 2007-01-11 2008-07-17 Natrol, Inc. Novel biphasic delivery system for a pharmaceutical or nutraceutical composition and method of administration
CN101011381A (zh) * 2007-02-12 2007-08-08 张国清 一种银杏内酯类药物的胃漂浮片及其制备方法
CN101444544A (zh) * 2008-12-09 2009-06-03 天津市弗兰德医药科技发展有限公司 一种银杏叶提取物微丸及其制备方法

Also Published As

Publication number Publication date
KR20140018913A (ko) 2014-02-13
EP2701688B1 (en) 2016-09-14
AR086062A1 (es) 2013-11-13
CN103429230A (zh) 2013-12-04
BR112013026236A2 (pt) 2020-11-10
BR112013026236B1 (pt) 2021-10-19
KR101912642B1 (ko) 2018-10-30
EP2701688A1 (en) 2014-03-05
CO6791614A2 (es) 2013-11-14
MX2011004417A (es) 2012-10-29
WO2012146592A1 (en) 2012-11-01

Similar Documents

Publication Publication Date Title
MX341428B (es) Tableta de liberacion controlada de extracto de ginkgo biloba y procedimiento para su obtencion.
AR114143A2 (es) Formulaciones de comprimidos revestidos
SG10201808050YA (en) BIOTECHNOLOGICAL PRODUCTION OF LNT, LNnT AND THE FUCOSYLATED DERIVATIVES THEREOF
BR112012001372A2 (pt) comprimido, e, métodos para preparar um comprimido e para a profilaxia ou tratamento de hiperfosfatemia.
MY179194A (en) Process for preparing therapeutic nanoparticles
MY174635A (en) Fast disintegrating solid dosage form formulation comprising functionalized calcium carbonate and method of their manufacture
AR092330A1 (es) Composiciones, metodos de absorcion transmucosa y metodo de tratamiento
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
IN2015KN00678A (es)
PE20190862A1 (es) Procedimiento de fabricacion de briquetas que contienen un compuesto de calcio y magnesio y un compuesto a base de hierro, y briquetas asi obtenidas
EP4233896A3 (en) Method for preparing an immunogenic lysate, the lysate obtained, dendritic cells loaded with such lysate and a pharmaceutical composition comprising the lysate or the dendritic cells
MX2015012526A (es) Inhibodores macrociclicos de cinasa rip2.
SG10201900648SA (en) Tablet formulation of 2-fluoro-n-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide
MX2013001793A (es) Producto para la esfera gastrica superior.
MX2014012799A (es) Tabletas recubiertas y la produccion de las mismas.
SG10201808038TA (en) Sildenafil Solutions and Methods of Making and Using Same
WO2014140911A3 (en) Diagnostic and therapeutic methods relating to microrna-144
PH12015500051B1 (en) Novel fermented milk product and method for producing the same
MX2015001648A (es) Composiciones que comprenden derivados de espicamicina y metodos de uso de los mismos.
WO2014027979A3 (en) Tablet formulations comprising tadalafil and dapoxetine
MX2023003000A (es) Formulaciones de liberacion modificada de viloxacina.
IN2013MU02576A (es)
IN2012DE00826A (es)
ZA201502156B (en) Bilayered composite tablet formulation comprising atorvastatin, irbesartan and magnesium carbonate
EA201592228A1 (ru) Соли налмефена в качестве лекарственных средств, предназначенных снижать потребление алкоголя или предотвращать избыточное потребление алкоголя

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: DR. WILLMAR SCHWABE GMBH & CO. KG

FG Grant or registration